adele atkins retweeted
The British Prime Minister Andy Burnham, installed by barely 25,000 voters in Makerfield constituency, has now shown his true colours.
May 2026: “I’m not proposing the UK rejoining the EU. I respect the decision that was made at the referendum.”
September: “I would like to see Britain join the EU in my lifetime. It’s not good enough to leave that question hanging.”
November: “The hard Brexit we were given was not good enough for Britain.”
Andy Burnham is just Keir Starmer 2.0; a liar, a fraud, and a traitor.
adele atkins retweeted
£700 MILLION.
That’s what Britain spent on the Rwanda scheme before Labour marched into Downing Street and scrapped it.
Now Germany, Austria, Greece, Denmark and the Netherlands are negotiating their OWN deportation hub in Rwanda.
Yes, the very same Rwanda.
Reports suggest the Europeans could end up using facilities originally developed for Britain’s abandoned scheme.
So British taxpayers forked out £700 million, Labour pulled the plug, and now five European governments could benefit from infrastructure we helped fund.
You couldn’t make it up.
Meanwhile, Andy Burnham has the brass neck to lecture us about Brexit costing Britain control of our borders.
Funny, isn’t it? We apparently needed the EU to control immigration, yet five EU governments are now exploring a policy involving the very country Labour abandoned.
Britain didn’t need Brussels’ permission to pursue Rwanda. Labour made its own decision to scrap the scheme.
And now we’re left with a £700 million bill and even larger annual payments to rejoin the EU. For what?
What an absolute farce.
Lilly’s Stipple deal has up to $5.9bn in milestones. Stipple takes a different route to targeting tumours, and Avacta already has early human data. It leaves the door open to a deal. My question for #AVCT: what more does big pharma need to see before it signs?
2
11
2,299
Big week ahead for #AVCT! 🚀
Investor meetings all week, followed by the AVA6207 presentation on Thursday.
Where do people see Avacta’s share price this time next week?
60p, 75p, £1+ or somewhere else?
Interested to hear your predictions! 👀
adele atkins retweeted
#AVCT With AVA6207's payload identities potentially being revealed on 19 November, here's a question.
If the ATR inhibitor belongs to a major pharmaceutical company, do you think that company could become an Avacta partner? 👀
38%Yes – very likely
36%Possibly – but not guaran
8%No – unrelated to partner
18%Too early to say
211 votes • Final results#AVCT What a turnaround from yesterday! 📈 Buyers stepping in, volume picking up and momentum improving. Can we push through that final hurdle and close at 60p or above today? 👀🚀
adele atkins retweeted
Man United put up for sale as football finance expert Stefan Borson reveals details
talksport.com/football/46989…
#AVCT When Avacta expressed excitement about AVA6207, management almost certainly already knew the key results being presented on 19 November.
The science hasn't deteriorated just because the SP has fallen.
Whoever is selling at 52p, it doesn't prove they know bad news. 👀
24
2,099
#AVCT With AVA6207's payload identities potentially being revealed on 19 November, here's a question.
If the ATR inhibitor belongs to a major pharmaceutical company, do you think that company could become an Avacta partner? 👀
38%Yes – very likely
36%Possibly – but not guaran
8%No – unrelated to partner
18%Too early to say
211 votes • Final results adele atkins retweeted
Buying #AVCT on a pump & it's soaring feels great - but you are exit liquidity. That is the moment of highest risk, yet it feels so safe.
Selling now: you're ENTRY liquidity. There's a FIGHT for your shares. Somebody knows what's coming. An 8x from £1, is now 15x from here.
#AVCT So much for 55p being the bottom! Already testing 53p this morning, yet sizeable buys are appearing at these levels. Is a large seller still unloading, or are buyers finally absorbing the stock? The science keeps progressing, but the SP tells a very different story.
#AVCT The SP keeps falling, yet the science continues to progress. Large trades at 55–56p suggest serious activity, but who's buying and selling remains unclear. With AVA6207 news and AVA6103 tumour data ahead, will the market finally start valuing the potential?
2
7
2,634
#AVCT The science keeps progressing, yet the SP remains stuck around 57p despite encouraging clinical data. The market wants more than scientific progress now. It wants commercial validation and funding certainty. A meaningful Pharma deal could change that picture overnight.
2
12
1,564
My Best Guess 🔮 #AVCT
Nov–Dec 2026: AVA6207 candidate news, possible AVA6103 tumour PK data.
Q1 2027: Further AVA6103 clinical evidence.
H1 2027: Initial efficacy results.
Q2 2027: Funding runway pressure unless a deal lands.
Could Big Pharma change this timeline?
3
1,074
adele atkins retweeted
🚨 Matheus Cunha on what Michael Carrick told Manchester United players at half-time that changed the spirit of the game:
“Honestly, I had never seen the manager that angry before. When we walked into the dressing room, he looked at every single one of us and said, ‘Nine games without a win. Is this really Manchester United? Is this what you think it means to wear this badge?’
He told us he had enough. He said, ‘I don’t care about reputations, salaries or how talented you think you are. If you cannot fight for this club, then you don’t deserve to be here. Do you understand what it takes to be a Manchester United player?’
Then he looked at us and said, ‘Do you remember when I played Roma in 2007? I was the first name on the scoreboard that night when we beat them 7-1. Now they’ve come here looking for revenge. Are you going to let them walk away with that satisfaction?’
He reminded us that Roma weren’t just playing against Manchester United; they were playing against our pride, our history and everything this badge represents.
Before we left the dressing room, he said, ‘Go out there and remind them who they’re playing against. I don’t want excuses. I want warriors. The fans are angry, everybody is angry, and they’ve had enough of us. They’ve given us enough time, enough chances, and I believe this could be our last opportunity to put things right.
We don’t know what will happen if we lose tonight. So stop thinking about yourselves, stop feeling sorry for yourselves and go out there and win this game. Fight for the badge, fight for the supporters and fight for each other.’
Honestly, something changed in that dressing room. We walked back onto that pitch with a completely different mentality.”
#AVCT The science is increasingly compelling. AVA6000 showing human efficacy signals, AVA6103 clinical proof of mechanism and AVA6207 promising preclinical results. Now it's time for commercial validation. How much more evidence does Big Pharma need before committing to a deal?
Agreed Mike. December's tumour PK and biopsy data could be pivotal, scientifically and commercially. Strong results could strengthen Avacta's negotiating position ahead of H1 efficacy data. The challenge is maximising deal value while managing the funding clock. #AVCT
1
992














